Fux CA - Search Results

1

Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study.

Calmy A, Fux CA, Norris R, Vallier N, Delhumeau C, Samaras K, Hesse K, Hirschel B, Cooper DA, Carr A. Calmy A, et al. Among authors: fux ca. J Infect Dis. 2009 Dec 1;200(11):1746-54. doi: 10.1086/644785. J Infect Dis. 2009. PMID: 19874178 Free article.

2

Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy.

Wunder DM, Bersinger NA, Fux CA, Mueller NJ, Hirschel B, Cavassini M, Elzi L, Schmid P, Bernasconi E, Mueller B, Furrer H; Swiss HIV Cohort Study. Wunder DM, et al. Among authors: fux ca. Antivir Ther. 2007;12(2):261-5. Antivir Ther. 2007. PMID: 17503668

3

Effect of tenofovir on renal glomerular and tubular function.

Fux CA, Christen A, Zgraggen S, Mohaupt MG, Furrer H. Fux CA, et al. AIDS. 2007 Jul 11;21(11):1483-5. doi: 10.1097/QAD.0b013e328216f15b. AIDS. 2007. PMID: 17589197

4

Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study.

Fux CA, Simcock M, Wolbers M, Bucher HC, Hirschel B, Opravil M, Vernazza P, Cavassini M, Bernasconi E, Elzi L, Furrer H; Swiss HIV Cohort Study. Fux CA, et al. Antivir Ther. 2007;12(8):1165-73. Antivir Ther. 2007. PMID: 18240857

5

Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study.

Wolbers M, Bucher HC, Furrer H, Rickenbach M, Cavassini M, Weber R, Schmid P, Bernasconi E, Hirschel B, Battegay M; Swiss HIV Cohort Study. Wolbers M, et al. HIV Med. 2008 Jul;9(6):397-405. doi: 10.1111/j.1468-1293.2008.00566.x. Epub 2008 Apr 10. HIV Med. 2008. PMID: 18410354 Free article.

6

CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.

Khanna N, Opravil M, Furrer H, Cavassini M, Vernazza P, Bernasconi E, Weber R, Hirschel B, Battegay M, Kaufmann GR; Swiss HIV Cohort Study. Khanna N, et al. Clin Infect Dis. 2008 Oct 15;47(8):1093-101. doi: 10.1086/592113. Clin Infect Dis. 2008. PMID: 18783328 Free article.

7

Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study.

Fux CA, Rauch A, Simcock M, Bucher HC, Hirschel B, Opravil M, Vernazza P, Cavassini M, Bernasconi E, Elzi L, Furrer H; Swiss HIV Cohort Study. Fux CA, et al. Antivir Ther. 2008;13(8):1077-82. Antivir Ther. 2008. PMID: 19195333

8

Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.

Khanna N, Elzi L, Mueller NJ, Garzoni C, Cavassini M, Fux CA, Vernazza P, Bernasconi E, Battegay M, Hirsch HH; Swiss HIV Cohort Study. Khanna N, et al. Among authors: fux ca. Clin Infect Dis. 2009 May 15;48(10):1459-66. doi: 10.1086/598335. Clin Infect Dis. 2009. PMID: 19348592 Free article.

9

Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals.

Elzi L, Kaufmann G, Weber R, Fux CA, Cavassini M, Hirschel B, Vernazza P, Bernasconi E, Battegay M; Swiss HIV Cohort Study. Elzi L, et al. Among authors: fux ca. HIV Clin Trials. 2009 Jul-Aug;10(4):207-14. doi: 10.1310/hct1004-207. HIV Clin Trials. 2009. PMID: 19723609

10

Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV.

Young J, Bucher HC, Guenthard HF, Rickenbach M, Fux CA, Hirschel B, Cavassini M, Vernazza P, Bernasconi E, Battegay M; Swiss HIV Cohort Study. Young J, et al. Among authors: fux ca. Antivir Ther. 2009;14(6):771-9. doi: 10.3851/IMP1291. Antivir Ther. 2009. PMID: 19812439 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

318 results

Search Page

Filters